ALUPENT Drug Patent Profile

✉ Email this page to a colleague

When do Alupent patents expire, and when can generic versions of Alupent launch?

Alupent is a drug marketed by Boehringer Ingelheim and is included in five NDAs.

The generic ingredient in ALUPENT is metaproterenol sulfate. There are six drug master file entries for this compound. Additional details are available on the metaproterenol sulfate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Alupent

A generic version of ALUPENT was approved as metaproterenol sulfate by CHARTWELL on July 22^nd, 1992.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for ALUPENT?
What are the global sales for ALUPENT?
What is Average Wholesale Price for ALUPENT?

Summary for ALUPENT

US Patents:	0
Applicants:	1
NDAs:	5
Raw Ingredient (Bulk) Api Vendors:	39
Patent Applications:	3,796
DailyMed Link:	ALUPENT at DailyMed

Drug patent expirations by year for ALUPENT

US Patents and Regulatory Information for ALUPENT

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	AEROSOL, METERED;INHALATION	016402-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	TABLET;ORAL	015874-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	SOLUTION;INHALATION	017659-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	SOLUTION;INHALATION	018761-002	Oct 10, 1986		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	SOLUTION;INHALATION	018761-001	Jun 30, 1983		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	TABLET;ORAL	015874-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	SYRUP;ORAL	017571-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ALUPENT

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	AEROSOL, METERED;INHALATION	016402-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	SYRUP;ORAL	017571-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	TABLET;ORAL	015874-002	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	TABLET;ORAL	015874-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	SOLUTION;INHALATION	017659-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	SOLUTION;INHALATION	018761-001	Jun 30, 1983	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for ALUPENT

See the table below for patents covering ALUPENT around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
African Intellectual Property Organization (OAPI)	1090		⤷ Sign Up
Switzerland	413863	Verfahren zur Herstellung neuer Aminoalkohole	⤷ Sign Up
Netherlands	120608		⤷ Sign Up
France	1466215	Procédé pour la préparation de nouveaux amino-alcools	⤷ Sign Up
Switzerland	410008	Verfahren zur Herstellung neuer Aminoalkohole	⤷ Sign Up
Sweden	310889		⤷ Sign Up
Netherlands	261247		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for ALUPENT

Make Better Decisions: Try a trial or see plans & pricing